<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31490941</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Retrospective longitudinal study of ALS in Cyprus: Clinical characteristics, management and survival.</ArticleTitle><Pagination><StartPage>e0220246</StartPage><MedlinePgn>e0220246</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0220246</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0220246</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Amyotrophic lateral sclerosis (ALS) is a rare, progressive neurodegenerative disease. There is heterogeneity of clinical phenotypes while a clinical characterization of ALS in Cyprus is still lacking. The aim of this 30-year retrospective study of ALS in Cyprus is to determine the demographic characteristics of patients, the clinical features of the disease, the uptake of supportive therapies and factors influencing survival.</AbstractText><AbstractText Label="METHODS">All ALS patients seen at the Cyprus Institute of Neurology and Genetics from January 1985 until July 2015 were included. Medical records of eligible patients were used for data extraction and compilation of an ALS database. Clinical features were compared between gender categories using univariate tests, while survival was assessed using Kaplan-Meier curves. Cox proportional hazards models were used to identify prognostic factors for survival.</AbstractText><AbstractText Label="RESULTS">One hundred and seventy-nine ALS patients were included in the study, of whom 7 had a positive family history. Most clinical characteristics of ALS did not differ from what is observed in other European countries. However, some clinical characteristics were unique to our population, such as an increased acceptability and utilisation of supportive treatments such as gastrostomy.</AbstractText><AbstractText Label="CONCLUSIONS">Overall, clinical characteristics of patients with ALS in the Republic of Cyprus do not differ from other European counties. Our study demonstrates a high acceptance and utilisation of supportive interventions enhancing survival, in the context of a multidisciplinary approach offered in the single tertiary centre that services the whole Cypriot ALS population. The findings of this paper are of value to the health professionals treating ALS in Cyprus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Demetriou</LastName><ForeName>Christiana A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Clinic D, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadjivasiliou</LastName><ForeName>Petros M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleopa</LastName><ForeName>Kleopas A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Clinic E, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christou</LastName><ForeName>Yiolanda P</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Neurology Clinic D, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leonidou</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neurology Clinic C, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyriakides</LastName><ForeName>Theodoros</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Clinic A, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamba-Papanicolaou</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7727-9714</Identifier><AffiliationInfo><Affiliation>Neurology Clinic D, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003535" MajorTopicYN="N" Type="Geographic">Cyprus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31490941</ArticleId><ArticleId IdType="pmc">PMC6730913</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0220246</ArticleId><ArticleId IdType="pii">PONE-D-19-04575</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17: 17&#x2013;23. 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. The Lancet. 2011;377: 942&#x2013;955. 10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwabara S, Sonoo M, Komori T, Shimizu T, Hirashima F, Inaba A, et al. Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve. 2008;37: 426&#x2013;430. 10.1002/mus.20949</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20949</ArticleId><ArticleId IdType="pubmed">18236469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, et al. Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Front Degener. 2013;14: 5&#x2013;18. 10.3109/21678421.2013.778548</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778548</ArticleId><ArticleId IdType="pmc">PMC3779649</ArticleId><ArticleId IdType="pubmed">23678876</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8: 94&#x2013;109. 10.1016/S1474-4422(08)70293-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70293-X</ArticleId><ArticleId IdType="pubmed">19081518</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis. Neurol Clin Pract. 2013;3: 313&#x2013;320. 10.1212/CPJ.0b013e3182a1b8ab</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0b013e3182a1b8ab</ArticleId><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9: 617&#x2013;628. 10.1038/nrneurol.2013.203</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41: 118&#x2013;130. 10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boum&#xe9;diene F, Logroscino G, Couratier P, Babron M-C, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2016; dyw061 10.1093/ije/dyw061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw061</ArticleId><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Demetriou CA, Hadjivasiliou PM, Kleopa KA, Christou YP, Leonidou E, Kyriakides T, et al. Epidemiology of Amyotrophic Lateral Sclerosis in the Republic of Cyprus: A 25-Year Retrospective Study. Neuroepidemiology. 2017;48: 79&#x2013;85. 10.1159/000477126</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000477126</ArticleId><ArticleId IdType="pubmed">28528330</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci. 1994;124 Suppl: 96&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Mot Neuron Disord Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2000;1: 293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur J Neurol. 2012;19: 360&#x2013;375. 10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol. 2005;12: 921&#x2013;938. 10.1111/j.1468-1331.2005.01351.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2005.01351.x</ArticleId><ArticleId IdType="pubmed">16324086</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Byrne S, Heverin M, Corr B, Elamin M, Staines A, et al. Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995&#x2013;2010. PLOS ONE. 2013;8: e74733 10.1371/journal.pone.0074733</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074733</ArticleId><ArticleId IdType="pmc">PMC3786977</ArticleId><ArticleId IdType="pubmed">24098664</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chi&#xf2; A, Mitchell D, Swingler RJ, et al. Incidence of Amyotrophic Lateral Sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81: 385&#x2013;390. 10.1136/jnnp.2009.183525</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin D, Lippa CF, Swearer JM. Cognition and amyotrophic lateral sclerosis (ALS). Am J Alzheimers Dis Other Demen. 2007;22: 300&#x2013;312. 10.1177/1533317507301613</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317507301613</ArticleId><ArticleId IdType="pubmed">17712161</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83: 102&#x2013;108. 10.1136/jnnp-2011-300188</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300188</ArticleId><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollefsen E, Midgren B, Bakke P, Fondenes O. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. Eur J Neurol. 2010;17: 1352&#x2013;1357. 10.1111/j.1468-1331.2010.03036.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.03036.x</ArticleId><ArticleId IdType="pubmed">20443984</ArticleId></ArticleIdList></Reference><Reference><Citation>Indrekvam S, Fondenes O, Gjerdevik M, Tysnes O-B, Rekand T, Bakke P. Longterm mechanical ventilation in ALS&#x2013;Outcome and perspective. A 12 year national register study of non-invasive and invasive ventilation in Norway. Eur Respir J. 2015;46: PA1571 10.1183/13993003.congress-2015.PA1571</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.congress-2015.PA1571</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP, et al. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol. 2009;65 Suppl 1: S24&#x2013;28. 10.1002/ana.21556</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21556</ArticleId><ArticleId IdType="pubmed">19191307</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Bono V, Marchese S, La Bella V. Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: clinical features and survival analysis. J Neurol Sci. 2012;323: 66&#x2013;70. 10.1016/j.jns.2012.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.08.011</ArticleId><ArticleId IdType="pubmed">22989611</ArticleId></ArticleIdList></Reference><Reference><Citation>Fini N, Georgoulopoulou E, Vinceti M, Monelli M, Pinelli G, Vacondio P, et al. Noninvasive and invasive ventilation and enteral nutrition for ALS in Italy. Muscle Nerve. 2014;50: 508&#x2013;516. 10.1002/mus.24187</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24187</ArticleId><ArticleId IdType="pubmed">24448736</ArticleId></ArticleIdList></Reference><Reference><Citation>Heritier-Barras A-C, Adler D, Iancu Ferfoglia R, Ricou B, Gasche Y, Leuchter I, et al. Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group. Swiss Med Wkly. 2013;143 10.4414/smw.2013.13830</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2013.13830</ArticleId><ArticleId IdType="pubmed">23925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Bermejo J, Hurbault A, Coup&#xe9; C, Meininger V, Similowski T. Soins palliatifs et ventilation m&#xe9;canique dans la scl&#xe9;rose lat&#xe9;rale amyotrophique (SLA). M&#xe9;decine Palliat Soins Support&#x2014;Accompagnement - &#xc9;thique. 2010;9: 309&#x2013;317. 10.1016/j.medpal.2010.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medpal.2010.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill CL, Williams TL, Peel ET, McDermott CJ, Shaw PJ, Gibson GJ, et al. Non-invasive ventilation in motor neuron disease: an update of current UK practice. J Neurol Neurosurg Psychiatry. 2012;83: 371&#x2013;376. 10.1136/jnnp-2011-300480</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300480</ArticleId><ArticleId IdType="pubmed">21849339</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G, et al. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81: 1141&#x2013;1143. 10.1136/jnnp.2009.175984</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.175984</ArticleId><ArticleId IdType="pubmed">20660920</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae JS, Hong Y-H, Baek W, Sohn EH, Cho J-Y, Kim B-J, et al. Current status of the diagnosis and management of amyotrophic lateral sclerosis in Korea: a multi-center cross-sectional study. J Clin Neurol Seoul Korea. 2012;8: 293&#x2013;300. 10.3988/jcn.2012.8.4.293</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2012.8.4.293</ArticleId><ArticleId IdType="pmc">PMC3540289</ArticleId><ArticleId IdType="pubmed">23323138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogino M. [End of life care for patients with ALS in Japan]. Rinsho Shinkeigaku. 2008;48: 973&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pubmed">19198135</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CT-C, Chiu Y-W, Wang K-C, Hwang C-S, Lin K-H, Lee I-T, et al. Riluzole and Prognostic Factors in Amyotrophic Lateral Sclerosis Long-term and Short-term Survival: A Population-Based Study of 1149 Cases in Taiwan. J Epidemiol. 2013;23: 35&#x2013;40. 10.2188/jea.JE20120119</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20120119</ArticleId><ArticleId IdType="pmc">PMC3700231</ArticleId><ArticleId IdType="pubmed">23117224</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami M, Kimura F, Nakajima H, Ishida S, Fujiwara S, Doi Y, et al. Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990&#x2013;2010. J Neurol Sci. 2014;344: 158&#x2013;164. 10.1016/j.jns.2014.06.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.06.047</ArticleId><ArticleId IdType="pubmed">25017882</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Chad DA, Pioro EP. Amyotrophic Lateral Sclerosis. Oxford: University Press, USA; 1998.</Citation></Reference><Reference><Citation>Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Effects of Demographic Factors on Survival Time after a Diagnosis of Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2015;44: 114&#x2013;120. 10.1159/000380855</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000380855</ArticleId><ArticleId IdType="pmc">PMC4533862</ArticleId><ArticleId IdType="pubmed">25792423</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77: 948&#x2013;950. 10.1136/jnnp.2005.083402</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.083402</ArticleId><ArticleId IdType="pmc">PMC2077622</ArticleId><ArticleId IdType="pubmed">16614011</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996&#x2013;2000. J Neurol Neurosurg Psychiatry. 2003;74: 1258&#x2013;1261. 10.1136/jnnp.74.9.1258</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.74.9.1258</ArticleId><ArticleId IdType="pmc">PMC1738639</ArticleId><ArticleId IdType="pubmed">12933930</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Sanders L, Fraser RJL. Nutritional support teams increase percutaneous endoscopic gastrostomy uptake in motor neuron disease. World J Gastroenterol. 2012;18: 6461&#x2013;6467; discussion p.6466. 10.3748/wjg.v18.i44.6461</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v18.i44.6461</ArticleId><ArticleId IdType="pmc">PMC3508641</ArticleId><ArticleId IdType="pubmed">23197892</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry. 2015;86: 496&#x2013;501. 10.1136/jnnp-2014-309601</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309601</ArticleId><ArticleId IdType="pubmed">25550416</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes RB, Colville S, Cran GW, Swingler RJ. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry. 2004;75: 1753&#x2013;1755. 10.1136/jnnp.2003.024364</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.024364</ArticleId><ArticleId IdType="pmc">PMC1738850</ArticleId><ArticleId IdType="pubmed">15548498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazamel M, Cutter G, Claussen G, Alsharabati M, Oh SJ, Lu L, et al. Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population. Amyotroph Lateral Scler Front Degener. 2013;14: 334&#x2013;337. 10.3109/21678421.2013.770030</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.770030</ArticleId><ArticleId IdType="pmc">PMC3732496</ArticleId><ArticleId IdType="pubmed">23458155</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E, Messina P, Logroscino G, Beghi E, SLALOM Group. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol. 2014;75: 287&#x2013;297. 10.1002/ana.24096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24096</ArticleId><ArticleId IdType="pubmed">24382602</ArticleId></ArticleIdList></Reference><Reference><Citation>Borasio GD, Gelinas DF, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol. 1998;245 Suppl 2: S7&#x2013;12; discussion S29.</Citation><ArticleIdList><ArticleId IdType="pubmed">9747928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Dupuis L, Petri S, Kollewe K, Abdulla S, Wolf J, et al. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. J Neurol. 2015;262: 849&#x2013;858. 10.1007/s00415-015-7646-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7646-2</ArticleId><ArticleId IdType="pubmed">25618254</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS ONE. 2017;12 10.1371/journal.pone.0177555</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177555</ArticleId><ArticleId IdType="pmc">PMC5441602</ArticleId><ArticleId IdType="pubmed">28542233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. In: Journal of Multidisciplinary Healthcare [Internet]. 19 May 2017. [cited 12 Oct 2018]. 10.2147/JMDH.S134992</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S134992</ArticleId><ArticleId IdType="pmc">PMC5446964</ArticleId><ArticleId IdType="pubmed">28579792</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens HE, Young J, Felgoise SH, Simmons Z. A Qualitative Study of Multidisciplinary ALS Clinic Use in the United States. Amyotroph Lateral Scler Front Degener. 2015;17: 55&#x2013;61. 10.3109/21678421.2015.1069851</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1069851</ArticleId><ArticleId IdType="pubmed">26508132</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, Chio&#x2019; A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79: 6&#x2013;11. 10.1136/jnnp.2006.104828</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.104828</ArticleId><ArticleId IdType="pubmed">18079297</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12: 310&#x2013;322. 10.1016/S1474-4422(13)70036-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>